David Alan Goodkin
Corporate Officer/Principal bei Goodkin Biopharma Consulting LLC
Profil
David Alan Goodkin is currently a Principal at Goodkin Biopharma Consulting LLC since 2007.
He was previously a Director at Venturi Ventures, Inc. from 2007 to 2010, Vice President-Clinical Research at Amgen, Inc. from 1992 to 2002, and Chief Medical Officer & SVP-Development at ICOS Corp.
from 2002 to 2007.
He also served as Vice President & Chief Medical Officer at Xenon Pharmaceuticals, Inc. from 2007 to 2009.
Dr. Goodkin received his undergraduate degree from Dartmouth College and his doctorate from New York University.
Aktive Positionen von David Alan Goodkin
| Unternehmen | Position | Beginn |
|---|---|---|
| Goodkin Biopharma Consulting LLC | Corporate Officer/Principal | 12.11.2009 |
Ehemalige bekannte Positionen von David Alan Goodkin
| Unternehmen | Position | Ende |
|---|---|---|
Venturi Ventures, Inc.
 Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | Direktor/Vorstandsmitglied | 26.08.2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
| XENON PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von David Alan Goodkin
| Dartmouth College | Undergraduate Degree |
| New York University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | Health Technology |
| Goodkin Biopharma Consulting LLC |
